However, additional GWAS analyses revealed significant associations between single nucleotide polymorphisms (SNPs) in the ERK1/2 genes, MAPK1 and MAPK3, in both MS onset [22] and severity [23] (Supp. This evidence concerns the gene MAPK3 and myeloid sarcoma.